መነሻ › ተደጋጋሚ እና የሚቀንስ ማልቲፕል ስክሌሮሲስ › Texas
በTexas ለተደጋጋሚ እና የሚቀንስ ማልቲፕል ስክሌሮሲስ የሚደረጉ ክሊኒካዊ ጥናቶች
ለተደጋጋሚ እና የሚቀንስ ማልቲፕል ስክሌሮሲስ የሚደረጉ 4 ጥናቶች በTexas ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
Official study text (English)
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- University of Texas Southwestern Medical Center: Division of Multiple Sclerosis and Neuroimmunology, Dallas
- Maxine Mesigner Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine Medical Center, Houston
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 55 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT04047628Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
- The University of Texas at Dallas, Richardson
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 65 · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT05958381Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0133, El Paso
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ10 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06408259The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
- The University of Texas at Austin, Austin
- The University of Texas Health Science Center at Houston, Houston
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ22 እስከ 60 · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06796504ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።